Further processing options
Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinib
Saved in:
Journal Title: | Blood |
---|---|
Authors and Corporations: | , , , , , , , , , , , , , , , |
In: | Blood, 125, 2015, 16, p. 2497-2506 |
Type of Resource: | E-Article |
Language: | English |
published: |
American Society of Hematology
|
Subjects: |